Cryo-Cell International I...

5.78
-0.04 (-0.69%)
At close: Apr 21, 2025, 3:49 PM
5.81
0.45%
After-hours: Apr 21, 2025, 08:00 PM EDT
-0.69%
Bid 4.93
Market Cap 46.71M
Revenue (ttm) 32.1M
Net Income (ttm) 128.71K
EPS (ttm) 0.01
PE Ratio (ttm) 578
Forward PE -582
Analyst Buy
Ask 6.68
Volume 12,801
Avg. Volume (20D) 14,736
Open 5.78
Previous Close 5.82
Day's Range 5.53 - 5.80
52-Week Range 4.96 - 9.50
Beta 0.69

About CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto...

Sector Healthcare
IPO Date Apr 4, 1994
Employees 82
Stock Exchange NASDAQ
Ticker Symbol CCEL
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for CCEL stock is "Buy." The 12-month stock price forecast is $8.5, which is an increase of 47.06% from the latest price.

Stock Forecasts

Earnings Surprise

Cryo-Cell International has released their quartely earnings on Apr 15, 2025:
  • Revenue of $7.97M exceeds estimates by $90K, with 1.53% YoY growth.
  • EPS of 0.03 exceeds estimates by 0.02, with -57.14% YoY decline.